Combination therapy with c-met and egfr antagonists

Details Combination therapy with c-met and egfr antagonists Combination therapy with c-met and egfr antagonists

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61K 31/517 (2006.01) A61K 45/06 (2006.01) A61P 35/00 (2006.01) C12N 5/02 (2006.01)

Patent

CA 2716851

The present invention relates generally to the fields of molecular biology and growth factor regula-tion. More specifically, the invention relates to combina-tion therapies for the treatment of pathological conditions, such as cancer comprising a c-met antagonist and a EGFR antagonist.

L'invention concerne, en général, les domaines de la biologie moléculaire et de la régulation du facteur de croissance. Elle concerne, plus particulièrement, des thérapies combinées servant à traiter des états pathologiques, tels que le cancer.

Affiliated with

Also associated with

Rating

Combination therapy with c-met and egfr antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination therapy with c-met and egfr antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy with c-met and egfr antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1621281